These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report. Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990 [TBL] [Abstract][Full Text] [Related]
3. [Polychemotherapy treatment with cisplatin, adriamycin, 5-fluorouracil (FAP) and cisplatin, adriamycin and cyclophosphamide (CISCA) in advanced transitional carcinoma of the bladder]. Sánchez Romero JA; Ramírez Ruiz F; Romero Fernández L; Pastor Gaitán P; Murillo Capitán E Actas Urol Esp; 1989; 13(4):240-2. PubMed ID: 2678934 [TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy]. Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260 [TBL] [Abstract][Full Text] [Related]
5. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)]. Fujioka H; Tada Y; Nakano E; Matsuda M; Osafune M; Sagawa S; Takaha M; Sonoda T Gan To Kagaku Ryoho; 1984 Aug; 11(8):1612-6. PubMed ID: 6541019 [TBL] [Abstract][Full Text] [Related]
6. Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study. Al-Sarraf M; Frank J; Smith JA; O'Bryan RM; Costanzi JJ; Stephens RL; Caraveo J; Crawford ED Cancer Treat Rep; 1985 Feb; 69(2):189-94. PubMed ID: 2578880 [TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of invasive bladder cancer]. Kotake T Gan To Kagaku Ryoho; 1991 Nov; 18(14):2375-82. PubMed ID: 1952956 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577 [TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant and adjuvant chemotherapy of bladder cancer]. Kuroda M; Kotake T Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116 [TBL] [Abstract][Full Text] [Related]
10. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study. Hussain MH; Glass TR; Forman J; Sakr W; Smith DC; Al-Sarraf M; Jones J; Balcerzak SP; Crawford ED; Grossman HB J Urol; 2001 Jan; 165(1):56-60; discussion 60-1. PubMed ID: 11125363 [TBL] [Abstract][Full Text] [Related]
11. [Systemic cisplatin-based chemotherapy in the treatment of advanced bladder cancer]. Boccon-Gibod L; Guinet F; Cressey-Kanoui C; Debré B; Steg A Ann Urol (Paris); 1985; 19(4):239-43. PubMed ID: 4040730 [TBL] [Abstract][Full Text] [Related]
12. [Complete remission of bladder cancer with multiple pulmonary metastases obtained by combined chemotherapy with cis-platinum, adriamycin and cyclophosphamide]. Takigawa H; Odachi M; Kagawa S; Kurokawa K Gan To Kagaku Ryoho; 1985 Sep; 12(9):1877-9. PubMed ID: 4041165 [TBL] [Abstract][Full Text] [Related]
13. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer. Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929 [TBL] [Abstract][Full Text] [Related]
14. [A study of combination chemotherapy with cis-diamminedichloroplatinum for advanced genitourinary carcinoma]. Nakatsu H; Nishimoto K; Moriyama H; Ehara S; Igawa M; Ishino T; Kodama M; Fujii M; Ukai R; Nihira H Gan To Kagaku Ryoho; 1982 Apr; 9(4):702-9. PubMed ID: 6892199 [TBL] [Abstract][Full Text] [Related]
15. cis-Platinum combination chemotherapy of bladder cancer: an update. Williams SD; Einhorn LH; Donohue JP Cancer Clin Trials; 1979; 2(4):335-8. PubMed ID: 394869 [TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy including adriamycin for advanced transitional cell carcinoma of the urinary tract. Kotake T; Usami M; Miki T; Kuroda M; Obata K; Osafune M; Fujioka H; Takasugi Y Cancer Chemother Pharmacol; 1983; 11 Suppl():S38-42. PubMed ID: 6685580 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic experiences of cis-diamminedichloroplatinum, adriamycin and 5-fluorouracil combination chemotherapy in advanced urothelial cancer, with special reference to adjuvant chemotherapy in invasive urothelial cancer]. Ogawa O; Yoshimura N; Taniguchi T; Nishimura K; Nakagawa T Hinyokika Kiyo; 1986 Jun; 32(6):795-802. PubMed ID: 3766338 [TBL] [Abstract][Full Text] [Related]
18. [[Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients]. Trifard F; Chrétien Y; Vallantin X; Collet C; Lachand AT; Dufour B Ann Urol (Paris); 1988; 22(3):216-9. PubMed ID: 3401004 [TBL] [Abstract][Full Text] [Related]
19. [Intraarterial chemotherapy via reservoir system for far-advanced bladder and prostate cancer]. Takahashi Y; Yamamoto N; Deguchi T; Kuriyama M; Yoh M; Yasuda M; Nakano M; Kawada Y; Takeuchi T; Shinoda I Gan To Kagaku Ryoho; 1998 Jul; 25(9):1310-3. PubMed ID: 9703815 [TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy of urothelial cancer with cisplatin, cyclophosphamide, doxorubicin and peplomycin: treatment of advanced cases and adjuvant chemotherapy after radical operation]. Seguchi T; Sakaguchi H; Kajikawa H; Nishioka T Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):600-5. PubMed ID: 2435245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]